Skip to Content

Clinical Trials Detail

Pulmonary Nodule Biomarker Trial

Objective
The Biomarkers for Diagnosis of Lung Nodules Study is a prospective study of a cohort of 600 individuals with lung nodules of indeterminate etiology that are identified by CT scans. Either biopsy or repeat CT scans must be clinically indicated to determine the etiology of the nodule. Patients will be asked to allow investigators access to CT scan images and spirometry data, and provide blood, sputum, urine, and exhaled breath samples over the course of the study. Patients will also be asked to allow investigators to access pathology records if a biopsy or surgical excision of the nodule is clinically indicated.
IRB Protocol Number
09-1106
Principal Investigator(s)
YORK MILLER

Cancer Trials

  • Lung Cancer
Sponsor(s)
UCCC
Contact
ERIN HIRSCH at
Eligibility and Other Participant Information
What To Expect : This is not a treatment trial. // Eligibility criteria : Main Inclusion Criteria: 1.Adult 18-85 years of age. 2.Patients referred to pulmonologists, oncologists, or thoracic surgeons for the evaluation of peripheral lung nodules found on CT scan. 3.Repeat CT scans, biopsy or surgical excision are clinically indicated to determine the etiology of the nodule. 4.One or more lung nodules must be between 5 mm and 50 mm in the greatest diameter. 5.Patients must be fully informed of the investigational nature of the procedure and sign an informed consent.